Allon Therapeutics, Inc. filed its Annual on Mar 27, 2013 for the period ending Dec 31, 2012. In this report its auditor, KPMG LLP - Klynveld Peat Marwick Goerdeler, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | +9,900.00% |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 14.11K | |
+25.83% | 46.56B | |
+45.38% | 41.67B | |
+0.69% | 41.16B | |
+30.52% | 32.4B | |
+22.30% | 28.18B | |
-6.35% | 28.1B | |
+49.25% | 14.52B | |
+49.18% | 13.74B | |
+3.45% | 12.17B |
- Stock Market
- Equities
- NPCUF Stock
- News Allon Therapeutics Inc.
- Allon Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt